Fundraising Fox

Octagon Therapeutics, Inc.

Providence, US · 1 known investors

Biotech

Founders & leadership

IS
Isaac StonerExecutive Officer, Director
TS
Thorne SparkmanDirector
RL
Ronald LennoxDirector

Investors · 1

Slater Technology FundreportedProvidencevia Thorne Sparkman · board

Reported raises · per SEC filings

Form D private placements
▶$11MraisedFeb 2024 · 53 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Isaac StonerExecutive Officer, Director
  • Thorne SparkmanDirector
  • Ronald LennoxDirector
Offering amount
$12.4M
Amount sold
$11M
First sale
Jan 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$398KraisedJun 2020 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Isaac StonerExecutive Officer, Director
  • Fred AusubelExecutive Officer, Director
Offering amount
$1M
Amount sold
$398K
First sale
Jun 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$511KraisedNov 2019 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul GoldenheimDirector
  • Isaac StonerExecutive Officer, Director
  • Fred AusubelExecutive Officer, Director
Offering amount
$511K
Amount sold
$511K
First sale
Nov 2019
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$537.6KraisedOct 2018 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Fred AusubelExecutive Officer, Director
  • Isaac StonerExecutive Officer, Director
  • Shen YuExecutive Officer, Director
  • Paul GoldenheimDirector
Offering amount
$1M
Amount sold
$537.6K
First sale
Oct 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.